539 related articles for article (PubMed ID: 25646888)
1. Decades after recovery from hepatitis B and HBsAg clearance the CD8+ T cell response against HBV core is nearly undetectable.
Kefalakes H; Jochum C; Hilgard G; Kahraman A; Bohrer AM; El Hindy N; Heinemann FM; Verheyen J; Gerken G; Roggendorf M; Timm J
J Hepatol; 2015 Jul; 63(1):13-9. PubMed ID: 25646888
[TBL] [Abstract][Full Text] [Related]
2. The characteristics of the cell-mediated immune response identify different profiles of occult hepatitis B virus infection.
Zerbini A; Pilli M; Boni C; Fisicaro P; Penna A; Di Vincenzo P; Giuberti T; Orlandini A; Raffa G; Pollicino T; Raimondo G; Ferrari C; Missale G
Gastroenterology; 2008 May; 134(5):1470-81. PubMed ID: 18355815
[TBL] [Abstract][Full Text] [Related]
3. Heat shock protein gp96 enhances humoral and T cell responses, decreases Treg frequency and potentiates the anti-HBV activity in BALB/c and transgenic mice.
Wang S; Qiu L; Liu G; Li Y; Zhang X; Jin W; Gao GF; Kong X; Meng S
Vaccine; 2011 Aug; 29(37):6342-51. PubMed ID: 21600951
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B surface antigen (HBsAg) and core antigen (HBcAg) combine CpG oligodeoxynucletides as a novel therapeutic vaccine for chronic hepatitis B infection.
Li J; Ge J; Ren S; Zhou T; Sun Y; Sun H; Gu Y; Huang H; Xu Z; Chen X; Xu X; Zhuang X; Song C; Jia F; Xu A; Yin X; Du SX
Vaccine; 2015 Aug; 33(35):4247-54. PubMed ID: 25858855
[TBL] [Abstract][Full Text] [Related]
5. Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B.
Le Bert N; Salimzadeh L; Gill US; Dutertre CA; Facchetti F; Tan A; Hung M; Novikov N; Lampertico P; Fletcher SP; Kennedy PTF; Bertoletti A
J Hepatol; 2020 Jan; 72(1):34-44. PubMed ID: 31348999
[TBL] [Abstract][Full Text] [Related]
6. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
7. Strong and multi-antigen specific immunity by hepatitis B core antigen (HBcAg)-based vaccines in a murine model of chronic hepatitis B: HBcAg is a candidate for a therapeutic vaccine against hepatitis B virus.
Akbar SM; Chen S; Al-Mahtab M; Abe M; Hiasa Y; Onji M
Antiviral Res; 2012 Oct; 96(1):59-64. PubMed ID: 22884884
[TBL] [Abstract][Full Text] [Related]
8. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
9. Immune correlates of hepatitis B surface antigen spontaneous seroconversion in hepatitis B e antigen negative chronic hepatitis B patients.
Vyas AK; Sharma BC; Sarin SK; Trehanpati N
Liver Int; 2018 Jan; 38(1):38-49. PubMed ID: 28500636
[TBL] [Abstract][Full Text] [Related]
10. Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro.
Shi M; Qian S; Chen WW; Zhang H; Zhang B; Tang ZR; Zhang Z; Wang FS
Clin Exp Immunol; 2007 Feb; 147(2):277-86. PubMed ID: 17223969
[TBL] [Abstract][Full Text] [Related]
11. T- and B-cell responses and previous exposure to hepatitis B virus in 'anti-HBc alone' patients.
Wang Q; Sachse P; Semmo M; Lokhande M; Montani M; Dufour JF; Zoulim F; Klenerman P; Semmo N
J Viral Hepat; 2015 Dec; 22(12):1068-78. PubMed ID: 26075501
[TBL] [Abstract][Full Text] [Related]
12. [The characteristic of T cells response to HBV-specific antigen proteins in patients with HBV infection].
Feng X; Yan HP; Liao HY; Liu YM; Zhang GY; Lin F; Zhao Y; Huang YL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Aug; 26(4):253-5. PubMed ID: 23189836
[TBL] [Abstract][Full Text] [Related]
13. Dynamic programmed death 1 expression by virus-specific CD8 T cells correlates with the outcome of acute hepatitis B.
Zhang Z; Zhang JY; Wherry EJ; Jin B; Xu B; Zou ZS; Zhang SY; Li BS; Wang HF; Wu H; Lau GK; Fu YX; Wang FS
Gastroenterology; 2008 Jun; 134(7):1938-49, 1949.e1-3. PubMed ID: 18455515
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression.
Salpini R; Colagrossi L; Bellocchi MC; Surdo M; Becker C; Alteri C; Aragri M; Ricciardi A; Armenia D; Pollicita M; Di Santo F; Carioti L; Louzoun Y; Mastroianni CM; Lichtner M; Paoloni M; Esposito M; D'Amore C; Marrone A; Marignani M; Sarrecchia C; Sarmati L; Andreoni M; Angelico M; Verheyen J; Perno CF; Svicher V
Hepatology; 2015 Mar; 61(3):823-33. PubMed ID: 25418031
[TBL] [Abstract][Full Text] [Related]
15. CD8+ T cell responses specific for hepatitis B virus core protein in patients with chronic hepatitis B virus infection.
Cao W; Qiu Z; Zhu T; Li Y; Han Y; Li T
J Clin Virol; 2014 Sep; 61(1):40-6. PubMed ID: 25049205
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic distribution of hepatitis B virus antigens in patients with and without hepatocellular carcinoma.
Safaie P; Poongkunran M; Kuang PP; Javaid A; Jacobs C; Pohlmann R; Nasser I; Lau DT
World J Gastroenterol; 2016 Mar; 22(12):3404-11. PubMed ID: 27022222
[TBL] [Abstract][Full Text] [Related]
17. TNF-α/IFN-γ profile of HBV-specific CD4 T cells is associated with liver damage and viral clearance in chronic HBV infection.
Wang H; Luo H; Wan X; Fu X; Mao Q; Xiang X; Zhou Y; He W; Zhang J; Guo Y; Tan W; Deng G
J Hepatol; 2020 Jan; 72(1):45-56. PubMed ID: 31499130
[TBL] [Abstract][Full Text] [Related]
18. In vitro use of autologous dendritic cells improves detection of T cell responses to hepatitis B virus (HBV) antigens.
Carotenuto P; Artsen A; Niesters HG; Osterhaus AD; Pontesilli O
J Med Virol; 2009 Feb; 81(2):332-9. PubMed ID: 19107973
[TBL] [Abstract][Full Text] [Related]
19. Intrahepatic CD8 T-lymphocytes and HBV core expression in relation to response to antiviral therapy for chronic hepatitis B patients.
Tang TJ; de Man RA; Kusters JG; Kwekkeboom J; Hop WC; van der Molen RG; Schalm SW; Janssen HL
J Med Virol; 2004 Feb; 72(2):215-22. PubMed ID: 14695662
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]